SITE001-0134

SITE001 (USA) › SITE001-0134

SITE001-0134

A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · Phase III
SITE001 (USA) · Dr. Reyes
consented 2026-01-29

enrolled

AEs

1

Serious

0

Dropout signal

–

Adverse events

1

Grade 2 Asthenia — outcome: RECOVERED/RESOLVED; onset 2022-12-06 (study day 115); relationship: NOT RELATED

moderate assessed

Data queries

0

No data queries. Open queries would appear here for this patient.